Photoneutron production mechanisms, their characteristics, and shielding strategies in high-energy linac environment: A review

Radiotherapy, a mainstay cancer treatment for patients worldwide, utilizes medical linear accelerators (linacs) with photon energies ranging from 4 MV to 25 MV. However, concerns arise at higher energies (>6 MV, particularly >10 MV). These high-energy photons interact with high-atomic number m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of radiation research and applied sciences 2024-09, Vol.17 (3), p.101031, Article 101031
Hauptverfasser: Uddin, Md Fakhar, Akter, Shirin, Ahmed, Mahiuddin, Sattar, Bushra Nufrin, Morshed, K.M. Mahabub, Osman, Hamid, Bokhari, Fawzi F., Alsufyani, Sultan J., Issa, Shams A.M., Khandaker, Mayeen Uddin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Radiotherapy, a mainstay cancer treatment for patients worldwide, utilizes medical linear accelerators (linacs) with photon energies ranging from 4 MV to 25 MV. However, concerns arise at higher energies (>6 MV, particularly >10 MV). These high-energy photons interact with high-atomic number materials in the linac head and collimation system, generating unwanted neutrons through (γ,n) reactions. This neutron contamination, present in both photon and electron beams, is a significant issue. Neutrons, with their high Linear Energy Transfer (LET), are more effective at causing clustered DNA damage (single and double-strand breaks). These neutrons not only impact shielding requirements in treatment rooms but also increase out-of-field radiation doses for patients receiving high-energy photon therapy. Therefore, for radiotherapy treatments exceeding 6 MV, additional precautions become crucial, including enhanced door shielding and optimized treatment planning. This review discusses in detail the multifaceted aspects of neutron production and shielding requirements during radiotherapy.
ISSN:1687-8507
1687-8507
DOI:10.1016/j.jrras.2024.101031